Skip to main content

Specimen Collection Manual and Test Catalog

  or
  or
  or

TRANSPLANT DONOR, HIV/HCV/HBV NAT PROCLEIX WITH REFLEXES

Geisinger Epic Procedure Code:  LAB4094    Geisinger Epic ID:  168399

SPECIMEN COLLECTION
Specimen type: 

EDTA plasma


Preferred collection container: 
Alternate collection container: 
3 mL lavender-top (K2 EDTA) tube
Specimen required: 

6 mL EDTA plasma; minimum 3 mL.


Special notes: 

This test is built for plasma only.



SPECIMEN PROCESSING
Processing instructions: 

Centrifuge and aliquot. Transport aliquot only (do not send original collection tube).


Transport temperature: 

Refrigerated.


Specimen stability: 

Room temperature: 72 hours. Refrigerated: 13 days. Frozen: 15 months.


Rejection criteria: 

Specimen type not marked on label.



TEST DETAILS
CPT code(s):  87801
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.
The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.

Test includes: 

If Donor, HIV/HCV/HBV NAT Procleix® is reactive, Donor, HIV-1 Discriminatory (CPT code(s): 87535), Donor, HBV Discriminatory (CPT code(s): 87516), and Donor, HCV Discriminatory (CPT code(s): 87521) will be performed at an additional charge.


Methodology: 
Nucleic acid amplification
Synonyms: 

Quest test code 19854


Clinical significance: 

Donor, HIV/HCV/HBV NAT Procleix® with Reflexes - The Procleix® Ultrio® Elite HIV/HBV/HCV Assay is a qualitative in vitro nucleic acid assay for the detection in Human Immunodeficiency Virus RNA, Hepatitis B Virus DNA, and Hepatitis C Virus RNA in human plasma. The test is intended to be used to screen blood, solid organ, and tissue donors for these agents. When used in conjunction with licensed tests for detecting antibodies to HIV, HBV, and HCV, test results may be used to determine eligibility for blood, solid organs, or tissue transplantation.


Doctoral Director(s): 
Randin Nelson MD
Review Date:  12/19/2024

Performing Locations